Cargando…

Perceptions of drug users regarding Hepatitis C screening and care: a qualitative study

BACKGROUND: Illicit drug users have a high prevalence of HCV and represent the majority of newly infected persons in the U.S. Despite the availability of effective HCV treatment, few drug users have been evaluated or treated for HCV. Racial and ethnic minorities have a higher incidence and prevalenc...

Descripción completa

Detalles Bibliográficos
Autores principales:	Jordan, Ashly E, Masson, Carmen L, Mateu-Gelabert, Pedro, McKnight, Courtney, Pepper, Nicole, Bouche, Katie, Guzman, Laura, Kletter, Evan, Seewald, Randy M, Des-Jarlais, Don C, Sorensen, James L, Perlman, David C
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2013
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3695813/ https://www.ncbi.nlm.nih.gov/pubmed/23786800 http://dx.doi.org/10.1186/1477-7517-10-10

Ejemplares similares

HSV-2 Co-Infection as a Driver of HIV Transmission among Heterosexual Non-Injecting Drug Users in New York City
por: Des Jarlais, Don C., et al.
Publicado: (2014)

Respondent-Driven Sampling in a Study of Drug Users in New York City: Notes from the Field
por: McKnight, Courtney, et al.
Publicado: (2006)

HSV-2 Infection as a Cause of Female/Male and Racial/Ethnic Disparities in HIV Infection
por: Des Jarlais, Don C., et al.
Publicado: (2013)

Modeling HIV transmission among persons who inject drugs (PWID) at the “End of the HIV Epidemic” and during the COVID-19 pandemic
por: Jarlais, Don Des, et al.
Publicado: (2022)

Non-fatal drug overdose among persons who inject drugs during first two years of the COVID-19 pandemic in New York City: Prevalence, risk factors
por: Jarlais, Don Des, et al.
Publicado: (2023)

COVID-19 vaccination and HIV transmission among persons who inject drugs during the first two years of the COVID-19 pandemic in New York City
por: Des Jarlais, Don C., et al.
Publicado: (2023)

Will "Combined Prevention" Eliminate Racial/Ethnic Disparities in HIV Infection among Persons Who Inject Drugs in New York City?
por: Des Jarlais, Don, et al.
Publicado: (2015)

Positive deviance control-case life history: a method to develop grounded hypotheses about successful long-term avoidance of infection
por: Friedman, Samuel R, et al.
Publicado: (2008)

Prescription opioid misuse and its relation to injection drug use and hepatitis C virus infection: protocol for a systematic review and meta-analysis
por: Jordan, Ashly E, et al.
Publicado: (2014)

Is your syringe services program cost-saving to society? A methodological case study
por: Des Jarlais, Don C., et al.
Publicado: (2021)

Emerging Zoonotic Infections, Social Processes and Their Measurement and Enhanced Surveillance to Improve Zoonotic Epidemic Responses: A “Big Events” Perspective
por: Friedman, Samuel R., et al.
Publicado: (2022)

Increasing HIV prevention and care for injecting drug users
por: Jarlais, Don C Des, et al.
Publicado: (2010)

Field Testing the “Avoid the Needle” Intervention for Persons at Risk for Transitioning to Injecting Drug Use in Tallinn, Estonia and New York City, USA
por: Jarlais, Don C Des, et al.
Publicado: (2023)

HIV risk and prevention among clients of a delivery-based harm reduction service during an HIV outbreak among people who use drugs in northern rural Minnesota, USA
por: Palayew, Adam, et al.
Publicado: (2023)

Risk factors for hepatitis C seropositivity among young people who inject drugs in New York City: Implications for prevention
por: Eckhardt, Benjamin, et al.
Publicado: (2017)

Potential geographic "hotspots" for drug-injection related transmission of HIV and HCV and for initiation into injecting drug use in New York City, 2011-2015, with implications for the current opioid epidemic in the US
por: Des Jarlais, D. C., et al.
Publicado: (2018)

Geographic distribution of risk (“Hotspots”) for HIV, HCV, and drug overdose among persons who use drugs in New York City: the importance of local history
por: Des Jarlais, D.C., et al.
Publicado: (2019)

Harm reduction in the USA: the research perspective and an archive to David Purchase
por: Des Jarlais, Don C.
Publicado: (2017)

HIV prevalence and gender differences among new injection-drug-users in Tallinn, Estonia: A persisting problem in a stable high prevalence epidemic
por: Uusküla, Anneli, et al.
Publicado: (2017)

Comparison of injecting drug users who obtain syringes from pharmacies and syringe exchange programs in Tallinn, Estonia
por: Vorobjov, Sigrid, et al.
Publicado: (2009)

Combination interventions for Hepatitis C and Cirrhosis reduction among people who inject drugs: An agent-based, networked population simulation experiment
por: Khan, Bilal, et al.
Publicado: (2018)

Toward a Theory of the Underpinnings and Vulnerabilities of Structural Racism: Looking Upstream from Disease Inequities among People Who Use Drugs
por: Friedman, Samuel R., et al.
Publicado: (2022)

Expanded syringe exchange programs and reduced HIV infection among new injection drug users in Tallinn, Estonia
por: Uusküla, Anneli, et al.
Publicado: (2011)

Hepatitis C virus infection among HIV-positive men who have sex with men: protocol for a systematic review and meta-analysis
por: Hagan, Holly, et al.
Publicado: (2014)

HTLV-1/2 is rare among Eastern-European intravenous drug users (IDUs)
por: Jõgeda, Ene-Ly, et al.
Publicado: (2015)

1215. A Mixed Methods Study on Severe Bacterial Infections in People Who Inject Drugs
por: Hrycko, Alexander, et al.
Publicado: (2021)

Sexual Health in Art and Science
por: Semaan, Salaam, et al.
Publicado: (2006)

HIV treatment, antiretroviral adherence and AIDS mortality in people who inject drugs: a scoping review
por: Uusküla, Anneli, et al.
Publicado: (2023)

“It’s like ‘liquid handcuffs”: The effects of take-home dosing policies on Methadone Maintenance Treatment (MMT) patients’ lives
por: Frank, David, et al.
Publicado: (2021)

Another frontier for harm reduction: contraceptive needs of females who inject drugs in Estonia, a cross-sectional study
por: Uusküla, Anneli, et al.
Publicado: (2018)

Syndemic factors associated with non-fatal overdose among young opioid users in New York City
por: Guarino, Honoria, et al.
Publicado: (2023)

Severe bacterial infections in people who inject drugs: the role of injection-related tissue damage
por: Hrycko, Alexander, et al.
Publicado: (2022)

HIV/Hepatitis Prevention in Drug Abuse Treatment Programs: Guidance From Research
por: Sorensen, James L., et al.
Publicado: (2002)

Considerations for the Development of a Substance-Related Care and Prevention Continuum Model
por: Perlman, David C., et al.
Publicado: (2017)

Reasons People Who Use Opioids Do Not Accept or Carry No-Cost Naloxone: Qualitative Interview Study
por: Bennett, Alex S, et al.
Publicado: (2020)

Metropolitan Social Environments and Pre-HAART/HAART Era Changes in Mortality Rates (per 10,000 Adult Residents) among Injection Drug Users Living with AIDS
por: Friedman, Samuel R., et al.
Publicado: (2013)

Using standardized methods for research on HIV and injecting drug use in developing/transitional countries: case study from the WHO Drug Injection Study Phase II
por: Des Jarlais, Don C, et al.
Publicado: (2006)

Social Support and Response to AIDS and Severe Acute Respiratory Syndrome
por: Nandi, Arijit, et al.
Publicado: (2008)

Social Factors Associated with AIDS and SARS
por: Des Jarlais, Don C., et al.
Publicado: (2005)

Rapid point-of-care (POC) testing for Hepatitis C antibodies in a very high prevalence setting: persons injecting drugs in Tallinn, Estonia
por: Uusküla, Anneli, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_e9ris8347hjckll02cn37ar1l0